These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12757410)

  • 1. Oxymorphone--Endo/Penwest: EN 3202, EN 3203.
    Drugs R D; 2003; 4(3):204-6. PubMed ID: 12757410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A; Ma C; Ahdieh H; Galer BS
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.
    Peniston JH; Gould E
    Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of oxymorphone extended release in postsurgical pain: a randomized clinical trial in knee arthroplasty.
    Ahdieh H; Ma T; Babul N; Lee D
    J Clin Pharmacol; 2004 Jul; 44(7):767-76. PubMed ID: 15199081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, tolerability, and effectiveness of oxymorphone extended release for moderate to severe osteoarthritis pain: a one-year study.
    McIlwain H; Ahdieh H
    Am J Ther; 2005; 12(2):106-12. PubMed ID: 15767827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial.
    Aqua K; Gimbel JS; Singla N; Ma T; Ahdieh H; Kerwin R
    Clin Ther; 2007 Jun; 29(6):1000-12. PubMed ID: 17692717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral extended-release oxymorphone: a new choice for chronic pain relief.
    Matsumoto AK
    Expert Opin Pharmacother; 2007 Jul; 8(10):1515-27. PubMed ID: 17661733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxymorphone extended-release tablets relieve moderate to severe pain and improve physical function in osteoarthritis: results of a randomized, double-blind, placebo- and active-controlled phase III trial.
    Matsumoto AK; Babul N; Ahdieh H
    Pain Med; 2005; 6(5):357-66. PubMed ID: 16266356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain.
    Katz N; Rauck R; Ahdieh H; Ma T; Gerritsen van der Hoop R; Kerwin R; Podolsky G
    Curr Med Res Opin; 2007 Jan; 23(1):117-28. PubMed ID: 17257473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study.
    Hale ME; Dvergsten C; Gimbel J
    J Pain; 2005 Jan; 6(1):21-8. PubMed ID: 15629415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxymorphone and oxymorphone extended release: a pharmacotherapeutic review.
    Sloan PA; Barkin RL
    J Opioid Manag; 2008; 4(3):131-44. PubMed ID: 18717508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting acceptability of titrated oxymorphone extended release in chronic low back pain - an individual patient analysis.
    Peniston JH; Xiang Q; Gould EM
    Curr Med Res Opin; 2010 Aug; 26(8):1861-71. PubMed ID: 20521870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxymorphone: a review.
    Prommer E
    Support Care Cancer; 2006 Feb; 14(2):109-15. PubMed ID: 16317569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of oral immediate-release oxymorphone for postsurgical pain.
    Gimbel J; Ahdieh H
    Anesth Analg; 2004 Nov; 99(5):1472-1477. PubMed ID: 15502051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical applications of oxymorphone.
    Vadivelu N; Maria M; Jolly S; Rosenbloom J; Prasad A; Kaye AD
    J Opioid Manag; 2013; 9(6):439-52. PubMed ID: 24481932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of oxymorphone in the management of chronic pain.
    Mayyas F; Fayers P; Kaasa S; Dale O
    J Pain Symptom Manage; 2010 Feb; 39(2):296-308. PubMed ID: 20152592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral oxymorphone (Opana).
    Med Lett Drugs Ther; 2007 Jan; 49(1251):3-4. PubMed ID: 17179898
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled study.
    Hale ME; Ahdieh H; Ma T; Rauck R;
    J Pain; 2007 Feb; 8(2):175-84. PubMed ID: 17145204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of oral oxymorphone in the elderly.
    Guay DR
    Consult Pharm; 2007 May; 22(5):417-30. PubMed ID: 17658959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of oxymorphone immediate release for the treatment of mild to moderate pain after ambulatory orthopedic surgery: results of a randomized, double-blind, placebo-controlled trial.
    Gimbel JS; Walker D; Ma T; Ahdieh H
    Arch Phys Med Rehabil; 2005 Dec; 86(12):2284-9. PubMed ID: 16344024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.